References
- Nnoaham KE, Hummelshoj L, Webster P, et al. Impact of endometriosis on quality of life and work productivity: a multicenter study across ten countries. Fertil Steril. 2011;96(2):366–373.
- As-Sanie S, Black R, Giudice LC, et al. Assessing research gaps and unmet needs in endometriosis. Am J Obstet Gynecol. 2019;221:86–94.
- Staal AHJ, van der Zanden M, Nap AW. Diagnostic delay of endometriosis in the Netherlands. Gynecol Obstet Invest. 2016;81(4):321–324.
- Soliman AM, Yang H, Du EX, et al. The direct and indirect costs associated with endometriosis: a systematic literature review. Hum Reprod. 2016;31(4):712–722.
- Burney RO, Giudice LC. Pathogenesis and pathophysiology of endometriosis. Fertil Steril. 2012;98:522–529.
- Ahn SH, Monsanto SP, Miller C, et al. Pathophysiology and immune dysfunction in endometriosis. BioMed Res Int. 2015;2015:1–12.
- Fassbender A, Burney RO, O DF, et al. Update on biomarkers for the detection of endometriosis. BioMed Res Int. 2015;2015:130854.
- Rakhila H, Al-Akoum M, Bergeron M-E, et al. Promotion of angiogenesis and proliferation cytokines patterns in peritoneal fluid from women with endometriosis. J Reprod Immunol. 2016;116:1–6.
- Rathore N, Kriplani A, Yadav RK, et al. Distinct peritoneal fluid ghrelin and leptin in infertile women with endometriosis and their correlation with interleukin-6 and vascular endothelial growth factor. Gynecol Endocrinol. 2014;30(9):671–675.
- Bedaiwy MA, Falcone T. Peritoneal fluid environment in endometriosis. Clinicopathological implications. Minerva Ginecol. 2003;55(4):333–345.
- May KE, Conduit-Hulbert SA, Villar J, et al. Peripheral biomarkers of endometriosis: a systematic review. Hum Reprod Update. 2010;16:651–674.
- Beste MT, Pfaffle-Doyle N, Prentice EA, et al. Molecular network analysis of endometriosis reveals a novel role for c-Jun regulated macrophage activation. Sci Transl Med. 2014;6:222ra16.
- Jørgensen H, Abby S, Hill BS, et al. Peritoneal fluid cytokines related to endometriosis in patients evaluated for infertility. Fertil Steril. 2017;107:1191–1199.
- Huang JC, Papasakelariou C, Dawood MY. Epidermal growth factor and basic fibroblast growth factor in peritoneal fluid of women with endometriosis. Fertil Steril. 1996;65:931–934.
- Wang TR, Yan LY, Yan J, et al. Basic fibroblast growth factor promotes the development of human ovarian early follicles during growth in vitro. Hum Reprod. 2014;29(3):568–576.
- Lee SR, Kim SH, Lee YJ, et al. Expression of epidermal growth factor, fibroblast growth factor-2, and platelet-derived growth factor-A in the eutopic endometrium of women with endometriosis. J Obstet Gynaecol Res . 2007;33:242–247.
- Siristatidis C, Vogiatzi P, Salamalekis G, et al. Granulocyte macrophage colony stimulating factor supplementation in culture media for subfertile women undergoing assisted reproduction technologies: a systematic review. Int J Endocrinol. 2013;2013:704967.
- Nasser C, Xin-Min T, Qingchuan D. The expression, activity and regulation of granulocyte macrophage-colony stimulating factor in human endometrial epithelial and stromal cells. MHR: Basic Science of Reproductive Medicine. 1999;5:459–466.
- Kunicki M, Łukaszuk K, Woclawek-Potocka I, et al. Evaluation of Granulocyte Colony-Stimulating Factor Effects on Treatment-Resistant Thin Endometrium in Women Undergoing IVF. BioMed Res Int. 2014;2014:1–5.
- Eftekhar M, Hosseinisadat R, Baradaran R, et al. Effect of granulocyte colony stimulating factor (G-CSF) on IVF outcomes in infertile women: An RCT. Int J Reprod Biomed (Yazd). 2016;14:341–346.
- Salmassi A, Schmutzler AG, Schaefer S, et al. Is granulocyte colony-stimulating factor level predictive for human IVF outcome? Hum Reprod. 2005;20(9):2434–2440.
- Keita M, Bessette P, Pelmus M, et al. Expression of interleukin-1 (IL-1) ligands system in the most common endometriosis-associated ovarian cancer subtypes. J Ovarian Res. 2010;3(1):3.
- Sahakian V, Anners J, Haskill S, et al. Selective localization of interleukin-1 receptor antagonist in eutopic endometrium and endometriotic implants. Fertil Steril. 1993;60:276–279.
- Zhang X, Wen J, Deng L, et al. Decreased levels of peritoneal interleukin-1 receptor antagonist in patients with endometriosis and disease-related dysmenorrhea. Fertil Steril. 2007;88(3):594–599.
- Capobianco A, Rovere-Querini P. Endometriosis, a disease of the macrophage. Front Immunol. 2013;4:9.
- Engelhardt E, Toksoy A, Goebeler M, et al. Chemokines IL-8, GROα, MCP-1, IP-10, and Mig are sequentially and differentially expressed during phase-specific infiltration of leukocyte subsets in human wound healing. Am J Pathol. 1998;153(6):1849–1860.
- Pizzo A, Salmeri FM, Ardita FV, et al. Behaviour of cytokine levels in serum and peritoneal fluid of women with endometriosis. Gynecol Obstet Invest. 2002;54(2):82–87.
- Kianpour M, Nematbakhsh M, Ahmadi SM, et al. Serum and peritoneal fluid levels of vascular endothelial growth factor in women with endometriosis. Int J Fertil Steril. 2013;7(2):96–99.
- Qiu Y, Hoareau-Aveilla C, Oltean S, et al. The anti-angiogenic isoforms of VEGF in health and disease. BiochemSoc Trans. 2009;37(6):1207–1213.
- Borrelli GM, Abrão MS, Mechsner S. Can chemokines be used as biomarkers for endometriosis? A systematic review. Hum Reprod. 2014;29(2):253–266.